Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of NATH BIO GENES. For more details, see the NATH BIO GENES quarterly results and NATH BIO GENES share price.
1 Day | % | 1.1 |
No. of shares | m | 19.00 |
1 Week | % | 0.7 |
1 Month | % | 4.3 |
1 Year | % | 21.1 |
52 week H/L | Rs | 243.7/150.6 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
NATH BIO GENES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 585 | 484 | 416 | 475 | 262 | |
Low | Rs | 328 | 126 | 137 | 193 | 128 | |
Sales per share (Unadj.) | Rs | 121.5 | 147.3 | 161.9 | 146.5 | 158.6 | |
Earnings per share (Unadj.) | Rs | 20.2 | 26.6 | 29.3 | -35.5 | 18.4 | |
Diluted earnings per share | Rs | 20.2 | 26.6 | 29.3 | -35.5 | 18.4 | |
Cash flow per share (Unadj.) | Rs | 21.0 | 27.3 | 30.8 | -33.8 | 20.0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 2.00 | 2.00 | 2.00 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 2.00 | 2.00 | 2.00 | |
Avg Dividend yield | % | 0 | 0 | 0.7 | 0.6 | 1.0 | |
Book value per share (Unadj.) | Rs | 267.1 | 293.5 | 322.8 | 285.2 | 301.7 | |
Adj. book value per share | Rs | 267.1 | 293.4 | 322.7 | 285.2 | 301.6 | |
Shares outstanding (eoy) | m | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | |
Price / Sales ratio | x | 3.8 | 2.1 | 1.7 | 2.3 | 1.2 | |
Avg P/E ratio | x | 22.6 | 11.5 | 9.4 | -9.4 | 10.6 | |
P/CF ratio (eoy) | x | 21.7 | 11.2 | 9.0 | -9.9 | 9.7 | |
Price / Book Value ratio | x | 1.7 | 1.0 | 0.9 | 1.2 | 0.6 | |
Dividend payout | % | 0 | 0 | 6.8 | -5.6 | 10.9 | |
Avg Mkt Cap | Rs m | 8,672 | 5,798 | 5,253 | 6,341 | 3,707 | |
Total wages/salary | Rs m | 164 | 187 | 237 | 248 | 233 |
NATH BIO GENES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,309 | 2,799 | 3,076 | 2,784 | 3,014 | |
Other income | Rs m | 23 | 18 | 17 | 19 | 6 | |
Total revenues | Rs m | 2,332 | 2,817 | 3,092 | 2,802 | 3,019 | |
Gross profit | Rs m | 434 | 548 | 668 | -516 | 488 | |
Depreciation | Rs m | 14 | 15 | 28 | 31 | 30 | |
Interest | Rs m | 53 | 67 | 89 | 106 | 102 | |
Profit before tax | Rs m | 389 | 485 | 568 | -634 | 362 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 4 | -20 | 11 | 40 | 12 | |
Profit after tax | Rs m | 384 | 505 | 557 | -674 | 350 | |
Gross profit margin | % | 18.8 | 19.6 | 21.7 | -18.5 | 16.2 | |
Effective tax rate | % | 1.1 | -4.1 | 1.9 | -6.2 | 3.2 | |
Net profit margin | % | 16.6 | 18.0 | 18.1 | -24.2 | 11.6 |
NATH BIO GENES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 4,098 | 4,723 | 5,361 | 4,678 | 5,208 | |
Current liabilities | Rs m | 1,387 | 1,696 | 1,730 | 1,943 | 2,165 | |
Net working cap to sales | % | 117.4 | 108.2 | 118.1 | 98.2 | 101.0 | |
Current ratio | x | 3.0 | 2.8 | 3.1 | 2.4 | 2.4 | |
Inventory Days | Days | 10 | 14 | 8 | 35 | 33 | |
Debtors Days | Days | 170,741,371 | 139,533,671 | 1,298 | 1,122 | 1,179 | |
Net fixed assets | Rs m | 2,382 | 2,569 | 2,534 | 2,717 | 2,720 | |
Share capital | Rs m | 190 | 190 | 190 | 190 | 190 | |
"Free" reserves | Rs m | 4,886 | 5,386 | 5,943 | 5,229 | 5,542 | |
Net worth | Rs m | 5,076 | 5,576 | 6,133 | 5,419 | 5,732 | |
Long term debt | Rs m | 5 | 3 | 7 | 7 | 4 | |
Total assets | Rs m | 6,479 | 7,293 | 7,895 | 7,395 | 7,928 | |
Interest coverage | x | 8.3 | 8.3 | 7.4 | -5.0 | 4.5 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | |
Return on assets | % | 6.8 | 7.8 | 8.2 | -7.7 | 5.7 | |
Return on equity | % | 7.6 | 9.1 | 9.1 | -12.4 | 6.1 | |
Return on capital | % | 8.7 | 9.9 | 10.7 | -9.7 | 8.1 | |
Exports to sales | % | 1.2 | 2.2 | 0.5 | 0.7 | 2.7 | |
Imports to sales | % | 1.6 | 1.4 | 1.4 | 0 | 0.3 | |
Exports (fob) | Rs m | 29 | 60 | 14 | 19 | 81 | |
Imports (cif) | Rs m | 36 | 40 | 43 | 0 | 10 | |
Fx inflow | Rs m | 29 | 60 | 14 | 19 | 81 | |
Fx outflow | Rs m | 45 | 42 | 46 | 6 | 17 | |
Net fx | Rs m | -16 | 18 | -31 | 13 | 64 |
NATH BIO GENES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -229 | 95 | 11 | 170 | 384 | |
From Investments | Rs m | -205 | -144 | -103 | -199 | -29 | |
From Financial Activity | Rs m | 201 | 56 | 164 | -222 | -17 | |
Net Cashflow | Rs m | -233 | 6 | 72 | -250 | 338 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Satish Kagliwal | COMP SEC: Dhiraj Rathi | YEAR OF INC: 2000 | BSE CODE: 537291 | FV (Rs): 10 | DIV YIELD (%): 1.1 |
Read: NATH BIO GENES 2022-23 Annual Report Analysis
More Agriculture Company Fact Sheets: ADANI PORTS & SEZ ADANI ENTERPRISES ZOMATO APOLLO HOSPITALS ADANI TOTAL GAS
Compare NATH BIO GENES With: ADANI PORTS & SEZ ADANI ENTERPRISES ZOMATO APOLLO HOSPITALS ADANI TOTAL GAS
It was indeed a volatile trading session for Indian share markets yesterday.